Paper19195051
Dysregulation of apoptosis in hepatocellular carcinoma cells.
Fabregat I. World J Gastroenterol, 2009. Cited by 232 papers, by iCite.
Cite this record
ConductScience Library. Dysregulation of apoptosis in hepatocellular carcinoma cells. Papers, record 19195051. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19195051
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apoptosis | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Aflatoxin B1 | |
| Animals | |
| Cell Death | |
| Cell Division | |
| Cell Survival | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Inflammation | |
| Kinetics | |
| Mice | |
| Mice, Transgenic | |
| Receptors, Death Domain | |
| Transforming Growth Factor beta | |
| Tumor Suppressor Protein p53 |
Source PubMed
References103
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16766264 | Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2. | Cancer Cell | 2006 | https://conductscience.org/library/papers/16766264 | PubMed |
| 2 | 17237271 | Deactivation of Akt and STAT3 signaling promotes apoptosis, inhibits proliferation, and enhances the sensitivity of hepatocellular carcinoma cells to an anticancer agent, Atiprimod. | Mol Cancer Ther | 2007 | https://conductscience.org/library/papers/17237271 | PubMed |
| 3 | 1649698 | Elevated levels of transforming growth factor beta messenger RNA and its polypeptide in human hepatocellular carcinoma. | Cancer Res | 1991 | https://conductscience.org/library/papers/1649698 | PubMed |
| 4 | 11244501 | Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis. | Oncogene | 2001 | https://conductscience.org/library/papers/11244501 | PubMed |
| 5 | 16007195 | Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma. | Oncogene | 2005 | https://conductscience.org/library/papers/16007195 | PubMed |
| 6 | 18722373 | E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer. | Gastroenterology | 2008 | https://conductscience.org/library/papers/18722373 | PubMed |
| 7 | 16083990 | Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression. | J Hepatol | 2005 | https://conductscience.org/library/papers/16083990 | PubMed |
| 8 | 9581679 | pp60c-src activation in hepatocellular carcinoma of humans and LEC rats. | Hepatology | 1998 | https://conductscience.org/library/papers/9581679 | PubMed |
| 9 | 16651430 | Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression. | Cancer Res | 2006 | https://conductscience.org/library/papers/16651430 | PubMed |
| 10 | 15856020 | Involvement of EGF receptor and c-Src in the survival signals induced by TGF-beta1 in hepatocytes. | Oncogene | 2005 | https://conductscience.org/library/papers/15856020 | PubMed |
| 11 | 3008986 | Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor. | Cancer Res | 1986 | https://conductscience.org/library/papers/3008986 | PubMed |
| 12 | 18318443 | Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells. | Hepatology | 2008 | https://conductscience.org/library/papers/18318443 | PubMed |
| 13 | 17401425 | TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. | Oncogene | 2007 | https://conductscience.org/library/papers/17401425 | PubMed |
| 14 | 18519678 | Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma. | Cancer Res | 2008 | https://conductscience.org/library/papers/18519678 | PubMed |
| 15 | 16937518 | Cyclooxygenases in hepatocellular carcinoma. | World J Gastroenterol | 2006 | https://conductscience.org/library/papers/16937518 | PubMed |
| 16 | 18349857 | Mechanisms of disease: epithelial-mesenchymal transition--does cellular plasticity fuel neoplastic progression? | Nat Clin Pract Oncol | 2008 | https://conductscience.org/library/papers/18349857 | PubMed |
| 17 | 18508316 | Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. | Int J Cancer | 2008 | https://conductscience.org/library/papers/18508316 | PubMed |
| 18 | 17055226 | Differential intracellular signalling induced by TGF-beta in rat adult hepatocytes and hepatoma cells: implications in liver carcinogenesis. | Cell Signal | 2007 | https://conductscience.org/library/papers/17055226 | PubMed |
| 19 | 11274632 | Expression of Fas and Fas-related molecules in human hepatocellular carcinoma. | Hum Pathol | 2001 | https://conductscience.org/library/papers/11274632 | PubMed |
| 20 | 15650183 | Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication. | J Virol | 2005 | https://conductscience.org/library/papers/15650183 | PubMed |
Cited by128
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 232 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42866451 | Fedratinib treatment correlates with suppressed STAT3/AKT/calpain-1 signaling and inhibits hepatocellular carcinoma progression. | Transl Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/42866451 | PubMed |
| 42589792 | Development and Optimization of Sodium Deoxycholate-Stabilised Shellac-Based Polymeric Nanoparticles for Enhanced Pharmacokinetics and Anticancer Activity of Etodolac in Hepatocellular Carcinoma. | Polymers (Basel) | 2026 | https://conductscience.org/library/papers/42589792 | PubMed |
| 41822802 | PSMD6 as a biomarker for hepatocellular carcinoma: A comprehensive bioinformatics analysis and in vitro validation. | Mol Clin Oncol | 2026 | https://conductscience.org/library/papers/41822802 | PubMed |
| 41035640 | HDAC inhibitor MS275 reprograms metabolism to induce differentiation and suppress proliferation in hepatocellular carcinoma. | Front Immunol | 2025 | https://conductscience.org/library/papers/41035640 | PubMed |
| 40606603 | Targeting super-enhancers in liver cancer: from pathogenic mechanisms to clinical applications. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40606603 | PubMed |
| 40546395 | Dose-dependent apoptotic effect of Woodfordia fruticosa on hepatocellular carcinoma (HepG2) cells by upregulating bax and caspase-9. | 3 Biotech | 2025 | https://conductscience.org/library/papers/40546395 | PubMed |
| 40141030 | Bid Protein: A Participant in the Apoptotic Network with Roles in Viral Infections. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40141030 | PubMed |
| 40069152 | VDAC2 and Bak scarcity in liver mitochondria enables targeting hepatocarcinoma while sparing hepatocytes. | Nat Commun | 2025 | https://conductscience.org/library/papers/40069152 | PubMed |
| 39659918 | Anti-carcinogenic effects and mechanisms of actions of Citrus limon fruit peel hydroethanolic extract and limonene in diethylnitrosmine/2-acetylaminofluorene-induced hepatocellular carcinoma in Wistar rats. | Am J Cancer Res | 2024 | https://conductscience.org/library/papers/39659918 | PubMed |
| 39589423 | Bioinspired caffeic acid-laden milk protein-based nanoparticles targeting folate receptors for breast cancer treatment. | Ther Deliv | 2025 | https://conductscience.org/library/papers/39589423 | PubMed |
| 39282575 | Polyvinyl Alcohol Capped Silver Nanostructures for Fortified Apoptotic Potential Against Human Laryngeal Carcinoma Cells Hep-2 Using Extremely-Low Frequency Electromagnetic Field. | Int J Nanomedicine | 2024 | https://conductscience.org/library/papers/39282575 | PubMed |
| 38672615 | Understanding the Role of Connexins in Hepatocellular Carcinoma: Molecular and Prognostic Implications. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38672615 | PubMed |
| 38671055 | Synthesis, bioactivity assessment, molecular docking and ADMET studies of new chromone congeners exhibiting potent anticancer activity. | Sci Rep | 2024 | https://conductscience.org/library/papers/38671055 | PubMed |
| 38424416 | Non-receptor Type PTPases and their Role in Controlling Pathways Related to Diabetes and Liver Cancer Signalling. | Curr Pharm Biotechnol | 2025 | https://conductscience.org/library/papers/38424416 | PubMed |
| 38107180 | Newly synthesized 6-substituted piperazine/phenyl-9-cyclopentyl containing purine nucleobase analogs act as potent anticancer agents and induce apoptosis via inhibiting Src in hepatocellular carcinoma cells. | RSC Med Chem | 2023 | https://conductscience.org/library/papers/38107180 | PubMed |
| 37941812 | Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2023 | https://conductscience.org/library/papers/37941812 | PubMed |
| 37902853 | Components of the JNK-MAPK pathway play distinct roles in hepatocellular carcinoma. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/37902853 | PubMed |
| 37624308 | Effect of Penthorum Chinense Pursh Compound on AFB1-Induced Immune Imbalance via JAK/STAT Signaling Pathway in Spleen of Broiler Chicken. | Vet Sci | 2023 | https://conductscience.org/library/papers/37624308 | PubMed |
| 37371138 | Starvation Protects Hepatocytes from Inflammatory Damage through Paradoxical mTORC1 Signaling. | Cells | 2023 | https://conductscience.org/library/papers/37371138 | PubMed |
| 36926129 | Collagen matrix scaffolds: Future perspectives for the management of chronic liver diseases. | World J Clin Cases | 2023 | https://conductscience.org/library/papers/36926129 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| BCL2L1 | 598 | PubTator's text mining | https://conductscience.org/library/genes/598 | NCBI Gene |
| BIRC2 | 329 | PubTator's text mining | https://conductscience.org/library/genes/329 | NCBI Gene |
| FASLG | 356 | PubTator's text mining | https://conductscience.org/library/genes/356 | NCBI Gene |
| MCL1 | 4170 | PubTator's text mining | https://conductscience.org/library/genes/4170 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
| TNFSF10 | 8743 | PubTator's text mining | https://conductscience.org/library/genes/8743 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
| XIAP | 331 | PubTator's text mining | https://conductscience.org/library/genes/331 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19195051
GET https://conductscience.org/api/papers/v1/19195051/references?page=2